Get started
Axonics, Inc.Axonics, Inc.Axonics, Inc.

Axonics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

AXNX chart


Full chart

AXNX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.60 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.11 USD
Net income (FY)
‪−6.09 M‬ USD
Revenue (FY)
‪366.38 M‬ USD
Shares float
‪50.31 M‬
Beta (1Y)
0.52

Employees


Employees (FY)
797
Change (1Y)
+187 +30.66%
Revenue / Employee (1Y)
‪459.70 K‬ USD
Net income / Employee (1Y)
‪−7.64 K‬ USD

About Axonics, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Raymond Wayne Cohen
Website
axonics.com
Headquarters
Irvine
Founded
2012
FIGI
BBG0067QVJ50
Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. The company was founded by Raymond W. Cohen, Guang Qiang Jiang, and Danny L. Dearen in March 2012 and is headquartered in Irvine, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

AXNX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AXNX is 70.42 USD — it has decreased by −0.04% in the past 24 hours. Watch Axonics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Axonics, Inc. stocks are traded under the ticker AXNX.
AXNX stock has fallen by −0.04% compared to the previous week, the month change is a 1.03% rise, over the last year Axonics, Inc. has showed a 31.63% increase.
We've gathered analysts' opinions on Axonics, Inc. future price: according to them, AXNX price has a max estimate of 75.00 USD and a min estimate of 71.00 USD. Watch AXNX chart and read a more detailed Axonics, Inc. stock forecast: see what analysts think of Axonics, Inc. and suggest that you do with its stocks.
AXNX reached its all-time high on Sep 15, 2022 with the price of 79.92 USD, and its all-time low was 11.95 USD and was reached on Nov 30, 2018. View more price dynamics on AXNX chart.
See other stocks reaching their highest and lowest prices.
AXNX stock is 0.14% volatile and has beta coefficient of 0.52. Track Axonics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Axonics, Inc. there?
Today Axonics, Inc. has the market capitalization of ‪3.60 B‬, it has increased by 0.01% over the last week.
Yes, you can track Axonics, Inc. financials in yearly and quarterly reports right on TradingView.
Axonics, Inc. is going to release the next earnings report on Mar 5, 2025. Keep track of upcoming events with our Earnings Calendar.
Axonics, Inc. revenue for the last quarter amounts to ‪116.19 M‬ USD, despite the estimated figure of ‪113.36 M‬ USD. In the next quarter, revenue is expected to reach ‪130.83 M‬ USD.
AXNX net income for the last quarter is ‪−21.00 K‬ USD, while the quarter before that showed ‪6.90 M‬ USD of net income which accounts for −100.30% change. Track more Axonics, Inc. financial stats to get the full picture.
No, AXNX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 797.00 employees. See our rating of the largest employees — is Axonics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Axonics, Inc. EBITDA is ‪7.27 M‬ USD, and current EBITDA margin is 2.37%. See more stats in Axonics, Inc. financial statements.
Like other stocks, AXNX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Axonics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Axonics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Axonics, Inc. stock shows the buy signal. See more of Axonics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.